Literature DB >> 26042194

Epigenetic Regulation by Sulforaphane: Opportunities for Breast and Prostate Cancer Chemoprevention.

Lauren L Atwell1, Laura M Beaver2, Jackilen Shannon3, David E Williams4, Roderick H Dashwood5, Emily Ho6.   

Abstract

Sulforaphane (SFN) is a phytochemical derived from cruciferous vegetables that has multiple molecular targets and anti-cancer properties. Researchers have demonstrated several chemopreventive benefits of SFN consumption, such as reductions in tumor growth, increases in cancer cell apoptosis, and disruption of signaling within tumor microenvironments both in vitro and in vivo. Emerging evidence indicates that SFN exerts several of its chemopreventive effects by altering epigenetic mechanisms. This review summarizes evidence of the impact of SFN on epigenetic events and how they relate to the chemopreventive effects of SFN observed in preclinical and clinical studies of breast and prostate cancers. Specific areas of focus include the role of SFN in the regulation of cell cycle, apoptosis, inflammation, antioxidant defense, and cancer cell signaling and their relationships to epigenetic mechanisms. Finally, remaining challenges and research needs for translating mechanistic work with SFN into human studies and clinical intervention trials are discussed.

Entities:  

Keywords:  breast; cancer; chemoprevention; epigenetics; prostate; sulforaphane

Year:  2015        PMID: 26042194      PMCID: PMC4450146          DOI: 10.1007/s40495-014-0002-x

Source DB:  PubMed          Journal:  Curr Pharmacol Rep        ISSN: 2198-641X


  97 in total

1.  DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells.

Authors:  Ashley G Rivenbark; Wendell D Jones; J Devon Risher; William B Coleman
Journal:  Epigenetics       Date:  2005-11-18       Impact factor: 4.528

2.  Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.

Authors:  Yan Y Sanders; James S Hagood; Hui Liu; Wei Zhang; Namasivayam Ambalavanan; Victor J Thannickal
Journal:  Eur Respir J       Date:  2014-03-06       Impact factor: 16.671

Review 3.  Multiple control of interleukin-8 gene expression.

Authors:  Elke Hoffmann; Oliver Dittrich-Breiholz; Helmut Holtmann; Michael Kracht
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

4.  Sulforaphane, erucin, and iberin up-regulate thioredoxin reductase 1 expression in human MCF-7 cells.

Authors:  Wei Wang; Shuran Wang; A Forbes Howie; Geoffrey J Beckett; Richard Mithen; Yongping Bao
Journal:  J Agric Food Chem       Date:  2005-03-09       Impact factor: 5.279

5.  The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells.

Authors:  Raymond Lo; Jason Matthews
Journal:  Toxicol Appl Pharmacol       Date:  2013-04-11       Impact factor: 4.219

6.  Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells.

Authors:  Tetsuhiro Chiba; Osamu Yokosuka; Makoto Arai; Motohisa Tada; Kenichi Fukai; Fumio Imazeki; Masaki Kato; Naohiko Seki; Hiromitsu Saisho
Journal:  J Hepatol       Date:  2004-09       Impact factor: 25.083

7.  Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer.

Authors:  Vered Stearns; Lisa K Jacobs; Maryjo Fackler; Theodore N Tsangaris; Michelle A Rudek; Michaela Higgins; Julie Lange; Zandra Cheng; Shannon A Slater; Stacie C Jeter; Penny Powers; Susanne Briest; Calvin Chao; Carl Yoshizawa; Elizabeth Sugar; Igor Espinoza-Delgado; Saraswati Sukumar; Edward Gabrielson; Nancy E Davidson
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

8.  The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells.

Authors:  Alexander V Gasparian; Ya Juan Yao; Dariusz Kowalczyk; Ludmila A Lyakh; Apollon Karseladze; Thomas J Slaga; Irina V Budunova
Journal:  J Cell Sci       Date:  2002-01-01       Impact factor: 5.285

9.  Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells.

Authors:  Laura D'Anello; Pasquale Sansone; Gianluca Storci; Valentina Mitrugno; Gabriele D'Uva; Pasquale Chieco; Massimiliano Bonafé
Journal:  Mol Cancer       Date:  2010-11-23       Impact factor: 27.401

10.  Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications.

Authors:  Syed M Meeran; Shweta N Patel; Yuanyuan Li; Samriddhi Shukla; Trygve O Tollefsbol
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

View more
  12 in total

1.  Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways.

Authors:  Da-Xuan Wang; Yu-Jiao Zou; Xi-Bin Zhuang; Shu-Xing Chen; Yong Lin; Wen-Lan Li; Jun-Jin Lin; Zhi-Qiang Lin
Journal:  Acta Pharmacol Sin       Date:  2016-11-28       Impact factor: 6.150

2.  The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.

Authors:  Besma Abbaoui; Kelly H Telu; Christopher R Lucas; Jennifer M Thomas-Ahner; Steven J Schwartz; Steven K Clinton; Michael A Freitas; Amir Mortazavi
Journal:  J Proteomics       Date:  2017-01-27       Impact factor: 4.044

Review 3.  Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

Authors:  Min Ji Bak; Soumyasri Das Gupta; Joseph Wahler; Nanjoo Suh
Journal:  Semin Cancer Biol       Date:  2016-03-22       Impact factor: 15.707

4.  A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells.

Authors:  Gavin S Johnson; Jia Li; Laura M Beaver; W Mohaiza Dashwood; Deqiang Sun; Praveen Rajendran; David E Williams; Emily Ho; Roderick H Dashwood
Journal:  Mol Nutr Food Res       Date:  2017-01-03       Impact factor: 5.914

Review 5.  Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway.

Authors:  Xuling Su; Xin Jiang; Lingbin Meng; Xiaoming Dong; Yanjun Shen; Ying Xin
Journal:  Oxid Med Cell Longev       Date:  2018-06-06       Impact factor: 6.543

6.  Preclinical Efficacy and Involvement of AKT, mTOR, and ERK Kinases in the Mechanism of Sulforaphane against Endometrial Cancer.

Authors:  Rajani Rai; Kathleen Gong Essel; Doris Mangiaracina Benbrook; Justin Garland; Yan Daniel Zhao; Vishal Chandra
Journal:  Cancers (Basel)       Date:  2020-05-18       Impact factor: 6.639

Review 7.  Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition.

Authors:  Lorena Avila-Carrasco; Pedro Majano; José Antonio Sánchez-Toméro; Rafael Selgas; Manuel López-Cabrera; Abelardo Aguilera; Guadalupe González Mateo
Journal:  Front Pharmacol       Date:  2019-07-30       Impact factor: 5.810

8.  Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression.

Authors:  Sangeetha Muthamilselvan; Abirami Raghavendran; Ashok Palaniappan
Journal:  PLoS One       Date:  2022-02-24       Impact factor: 3.240

9.  Two Novel Flavin-Containing Monooxygenases Involved in Biosynthesis of Aliphatic Glucosinolates.

Authors:  Wenwen Kong; Jing Li; Qingyue Yu; Wei Cang; Rui Xu; Yang Wang; Wei Ji
Journal:  Front Plant Sci       Date:  2016-08-29       Impact factor: 5.753

Review 10.  Combinatorial Epigenetics Impact of Polyphenols and Phytochemicals in Cancer Prevention and Therapy.

Authors:  Itika Arora; Manvi Sharma; Trygve O Tollefsbol
Journal:  Int J Mol Sci       Date:  2019-09-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.